NovaBay regains compliance with NYSE American continued listing standards

NovaBay (NBY) Pharmaceuticals announced that it has regained compliance with the NYSE American’s continued listing standards. As previously disclosed, the NYSE American notified the company on April 18, 2024 and May 28, 2024 that it was not in compliance with the continued listing standards of the NYSE American Company Guide. Specifically, the notifications indicated that the company was not in compliance with Sections 1003(a)(i), 1003(a)(ii) and 1003(a)(iii) of the company guide, requiring a listed company to have stockholders’ equity of at least $6 million.